Skip to main content

Table 1 Results of drug susceptibility test against Mycobacterium massiliense

From: Clinical features and treatment outcomes of septic arthritis due to Mycobacterium massiliense associated with intra-articular injection: a case report

Minimum inhibitory concentration (μg/ml) of antibiotics

Patient number

AK

CFX

CIP

CLA

DOX

IMP

MXF

TMP/

SMX

LNZ

1

16

S

32

I

8

R

≤0.5

S

32

R

8

I

2

I

4/76

R

≤2

S

2

16

S

32

I

4

R

≤0.5

S

8

R

8

I

2

I

8/152

R

4

S

3

Not checked

4

16

S

64

I

16

R

≤0.5

S

16

R

16

I

4

R

16/304

R

8

S

5

16

S

16

S

8

R

≤0.5

S

>32

R

4

S

2

I

4/76

R

4

S

6

Not isolated

7

Not checked

8

8

S

32

I

8

R

≤0.5

S

>32

R

4

S

4

R

4/76

R

≤2

S

9

16

S

16

S

16

R

≤0.5

S

>32

R

8

I

8

R

8/152

R

4

S

  1. AK amikacin, CFX cefoxitin, CIP ciprofloxacin, CLA clarithromycin, DOX doxycycline, IMP imipenem, MXF moxifloxacin, TMP/SMX trimethoprim/sulfamethoxazole, LNZ linezolid, S susceptible, I intermediate, R resistant